Longevity Life Sciences was proud to be a major sponsor the Wellspring Longevity Conference on the Gold Coast, where leaders across science, wellness, and innovation gathered to explore the future of human healthspan.
A major highlight was the NAD⁺ panel discussion, featuring Professor Sophie Stocker (University of Sydney), Dr Teresa Nicoletti (Mills Oakley), and Dr Ross Walker, who together brought a uniquely evidence-based and clinically grounded perspective on the role of NAD⁺ and NMN in supporting cellular resilience.
Renowned Longevity Researcher, Professor Sinclair’s keynote explored the rapidly evolving science behind NAD⁺ biology and its influence on energy production, metabolic health, and healthy ageing. The conversation across the panel reinforced several key themes:
- NAD⁺ is emerging as a central regulator of cellular health, with increasing evidence supporting its role in maintaining vitality as we age.
- NMN continues to show strong promise as a safe and effective NAD⁺ precursor, further strengthened by Australia’s recent TGA decision permitting its use in listed medicines.
- Advanced delivery technologies and high-quality clinical studies will shape the next generation of longevity interventions, raising both expectations and standards in the sector.
- Collaboration between researchers, clinicians, regulators, and industry is essential to responsibly advance the field and translate complex science into meaningful health outcomes.
For Longevity Life Sciences, Wellspring underscored the importance of rigorous science, credible regulation, and translational research in building the future of evidence-based longevity solutions. The strong engagement from practitioners and the broader community highlighted the growing global appetite for trusted, clinically supported approaches to cellular health.
We extend our thanks to the Wellspring organisers, our fellow speakers, and the community who joined us. LLS is proud to contribute to this momentum and remains committed to advancing research, education, and responsible innovation in longevity science.
